Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins

Blood

Volumn 87, Issue 12, 1996, Pages 5104-5112

  Harris, Paul E ^a,b   Maffei, Antonella ^a   Colovai, Adriana I ^a   Kinne, Johnathan ^a   Tugulea, Sorina ^a   Suciu Foca, Nicole ^a  

^a Columbia University ^*  (United States)

^b P and S 14 401 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL PROTEIN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; COLONY FORMING UNIT GM; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HLA SYSTEM; HUMAN; HUMAN CELL; HYBRIDOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0029938883     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5104.bloodjournal87125104     Document Type: Article

References (43)

1. Unanue ER: Antigen presenting functions of the macrophage. Annu Rev Immunol 2:395, 1984
2. Guardiola J, Maffei A: Control of MHC class II gene expression in autoimmune, infectious and neoplastic diseases. Crit Rev Immunol 13:247, 1993.
3. Gorga JC: Structural analysis of class II major histocompatibility complex proteins. Crit Rev Immunol 11:305, 1992
4. Alonso MC, Navarrete CV, Solana R, Torres A, Pena-Martinez J, Festenstein H: Differential expression of HLA-DR and HLA-DQ antigens on normal cells of the myelomonocytic lineage. Tissue Antigens 26:310, 1985
5. Koeffler HP, Golde DW: Acute myelogenous leukemia: A human cell line responsive to colony stimulating activity. Science 200:1153, 1978
6. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW: An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56:265, 1980
7. Han T, Minowada J: Expression of MLR-S in human myeloid, monocytic and erythroid cell differentiation. J Clin Lab Immunol 4:169, 1980
8. Oblakowski P, Bello-Fernandez C, Reittie JE, Heslop HE, Galatowics G, Veys P, Wilkes S, Prentice HG, Hazelhurst G, Hoffbrands AV: Possible mechanism of selective killing of myeloid leukemic cells by lymphokine-activated killer cells. Blood 77:1996, 1991
9. Harris PE, Maffei A, Liu Z, Colovai AI, Reed EF, Inghirami G, Suciu-Foca N: Naturally processed cytokine-derived peptide bound to HLA-class II molecules. J Immunol 151:5975, 1993
10. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26:171, 1980
11. Lampson LA, Levy R: Two populations of Ia-like molecules on a human B cell line. J Immunol 125:293, 1980
12. Arunachalam B, Lamb CA, Cresswell P: Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int Immunol 6:439, 1993
13. Denzin LK, Robbins NF, Carboy-Newcomb C, Cresswell P: Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cell. Immunity 1:595, 1994
14. Harris PE, Lupu F, Hong B, Reed EF, Suciu-Foca N: Differentiation stage specific "self" peptides bound by MHC-class I molecules. J Exp Med 177:783, 1993
15. +, CD38-hematopoietic stem cells. Blood 83:1515, 1994
16. Chirgwin JM, Przybyla AE, McDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acids from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
17. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
18. Harris PE, Colovai AI, Liu Z, Dalla-Favera R, Suciu-Foca N: Naturally processed MHC class I bound peptides from c-myc transfected B cells reveal allele specific motifs. J Immunol 151:5966, 1993
19. Frumento G, Harris PE, Gawinowicz MA, Suciu-Foca N, Pernis B: Sequence of a prominent 16-residue self peptide bound to HLA-B27 in a lymphoblastoid cell line. Cell Immunol 152:623, 1993
20. Colovai AI, Suciu-Foca N, Baiulescu GE, Harris PE: HLA-class I self peptides isolated from a T cell leukemia reveal the allelespecific motif of HLA-B38. Tissue Antigens 44:65, 1994
21. Harris PE, Colovai AI, Maffei A, Liu Z, Suciu-Foca N: MHC class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line. Immunology 86:606, 1995
22. Newcomb JR, Cresswell P: Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated ab dimers. J Immunol 150:499, 1993
23. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL: Predominant naturally-processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature 358:764, 1992
24. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178:27, 1993
25. k. Proc Natl Acad Sci USA 89:7380, 1992
26. Gordon RD, Young JA, Rayner S, Luke RWA, Crowther ML, Wordsworth P, Bell J, Hassall G, Evans J, Hinchliffe SA, Culbert EJ, Davidson MD: Purification and characterization of endogenous peptides extracted from HLA-DR isolated from the spleen of a patient with rheumatoid arthritis. Eur J Immunol 25:1473, 1995
27. Cresswell P: Assembly,transport, and function of MHC class II molecules Annu Rev Immunol 12:259, 1994
28. Denzin LK, Cresswell P: HLA-DM induces CLIP dissociation from MHC class II ab dimers and facilitates peptide loading. Cell 82:155, 1995
29. Machamer CE, Cresswell P: Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J Immunol 129:2564, 1982
30. Germain RN, Margulies D: The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403, 1993
31. Hammer J, Vlsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F: Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:97, 1993
32. Brown JH, Jardetzky TS, Gorga JC, Stem LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR 1. Nature 364:33, 1993
33. Guagliardi LE, Koppelman B, Blum JS, Marks MS, Cresswell P, Brodsky FM: Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343:133, 1990
34. Mouritsen S, Hansen AS, Petersen BL, Buus S: pH dependence of the interaction between immunogenic peptides and MHC molecules: Evidence for an acidic intracellular compartment being the organelle of interaction. J Immunol 148:1438, 1992
35. Riberdy JM, Avva RR, Geuze HJ, Cresswell P: Transport and intracellular Distribution of the MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines. J Cell Biol 125:1225, 1994
36. Harris PE: Self peptides bound to HLA molecules. Crit Rev Immunol 41:61, 1994
37. Avva RR, Cresswell P: In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides: Immunity 1:763, 1994
38. Nuchtern JG, Biddison WE, Klausner RD: Class II molecules can use the endogenous pathway of antigen presentation. Nature 343:74, 1990
39. Jaraquemada D, Marti M, Long EO: An endogenous processing pathway in vaccinia virus-infected cells for the presentation of cytoplasmic antigens to class II restricted T cells. J Exp Med 172:947, 1990
40. Malnati MS, Marti M, LaVaute T, Jaraquemada D, Biddison W, DeMars R, Long EO: Processing pathways for presentation of cytosolic antigens to MHC class II restricted T cells. Nature 357:702, 1992
41. Seglen PO, Bohley P: Autophagy and other vacuolar protein degradation mechanisms. Experientia 48:158, 1992
42. Bix M, Raulet D: Ineffecient positive selection directed by haematopoietic cells. Nature 359:330, 1992
43. Hill CM, Hayball J, Allison AA, Rothbard JB: Conformational and structural characteristics of peptide binding to HLA-DR. J Immunol 147:189, 1991